Livsvitenskapskonferansen 2023 scorer h?yt blant deltakerne
Konferansen som ble relansert under navnet Norway Life Science - Livsvitenskapskonferansen i 2023, har som ambisjon ? v?re Norges viktigste m?teplass for alle akt?rer innen livsvitenskap. Evalueringen viser at deltakerne var sv?rt forn?yde med ?rets konferanse.
Konferansen med tittelen ?Life Science and Technology Transforming our Future? var fokusert p? hvordan utvikle en sterk helsen?ring i Norge. Blant h?ydepunktene var presentasjonen av rapporten ?Building Norway’s Life Science Industry? fra Boston Consulting Group, innlegg ved styreleder i Novo Nordisk Helge Lund og n?ringsminister Jan Christian Vestres lansering av et veikart for helsen?ringen. Bruk av eksternt konferansested gjorde det mulig ? ha parallellsesjoner, som var en nytt tilbud p? konferansen og som ble godt mottatt av deltakerne.
Se bilder fra konferansen
Interaction between research, industry and authorities
Keynote speaker Anna-Lena Engwall, Country President Nordic, AstraZeneca
Foto: Even Kleppa/Kleppa Media/University of Oslo
How can public-private partnerships improve access to innovation and improve healthcare?
?slaug Helland, UiO/Oslo University Hospital and Eli Bergli, Novartis Norway gave a presention in the parallel sessions.
Foto: Even Kleppa/Kleppa Media/University of Oslo
Facilitating research-based innovation
Carl Henrik G?rbitz in dialogue with President of The Student Parliament Oline Marie S?ther, Hilde Nebb, Innovation Director and Professor at UiO Growth House and Agnete Fredriksen, Chief Business Officer & Co-founder, Nykode Therapeutics.
Foto: Even Kleppa/Kleppa Media/University of Oslo
Innovation in digital migraine treatment
Presented by CEO and Co-founder of Nordic Brain Tech, Cathrine Ro Heuch .
Foto: Even Kleppa/Kleppa Media/University of Oslo
Building Norway's Life Science Industry
Gustav Gotteberg presented the findings in the report prepared by Boston Consulting Group.
Foto: Even Kleppa/Kleppa Media/University of Oslo
"New Norwegian health industry - prerequisites for success"
Chairman of the board, Novo Nordisk, Helge Lund gave the keynote speech.
Foto: Even Kleppa/Kleppa Media/University of Oslo
The hosts of Norway Life Science 2023
Christine Wergeland S?rbye, CEO, Oslo Science City and Carl Henrik G?rbitz, Director UiO:Life Science
Foto: Even Kleppa/Kleppa Media/University of Oslo
Parallel Session: Artificial Intelligence
Professor Ingrid Glad, UiO, talked about the plans for the new Centre of Excellence, Integreat: The Norwegian Center for Knowledge-Driven Machine Learning.
Foto: Even Kleppa/Kleppa Media/University of Oslo
Panel "Interaction between research, industry and authorities"
From left: Country President Nordic AstraZeneca, Anna-Lena Engwall , Alexandra Bech Gj?rv, President and CEO, SINTEF, Cathrine Lofthus, Secretary General, Ministry of Health and Care Services, Jenni Nordborg, Director International Affairs, Lif and Jan Terje Andersen, Professor, Department of Pharmacology, UiO and Group leader Oslo University Hospital.
Foto: Even Kleppa/Kleppa Media/University of Oslo
Opening of Norway Life Science 2023
Jan Christian Vestre, Minister of Trade and Industry gives the opening speech.
Foto: Even Kleppa/Kleppa Media/University of Oslo
Convergence between medicine and technology
Max Wegner, Senior Vice President, Head of Regulatory Affairs, Bayer.
Foto: Even Kleppa/Kleppa Media/University of Oslo
Setting the stage of Norway Life Science 2023
The hosts Christine Wergeland S?rbye CEO, Oslo Science City and Carl Henrik G?rbitz, Director, UiO:Life Science on stage.
Foto: Even Kleppa/Kleppa Media/University of Oslo
Panel discussion "New Norwegian health industry - prerequisites for success"
From left: Moderator Torbj?rn R?e Isaksen, Chairman of the board, Novo Nordisk, Helge Lund, Director General of NHO, Ole Erik Almlid and Gustav Gotteberg, Managing Director & Senior Partner, Boston Consulting Group Oslo.
Foto: Even Kleppa/Kleppa Media/University of Oslo
A dialogue about the Norwegian knowledge-base
Participants:
Bj?rn Atle Bj?rnbeth, CEO, Oslo University Hospital
Leif Rune Skymoen, Newly appointed General Manager LMI
Arnoldo Frigessi, Professor, Department of Biostatistics, UiO
Chair: Carl Henrik G?rbitz, Director, UiO:Life Science (left)
Foto: Even Kleppa/Kleppa Media/University of Oslo
Setting the stage of Norway Life Science 2023
Governing Mayor of Oslo, Raymond Johansen talks at the opening of Norway Life Science 2023.
Foto: Even Kleppa/Kleppa Media/University of Oslo
Welcome to Norway Life Science 2023 by Rector Svein St?len
Foto: Even Kleppa/Kleppa Media/University of Oslo
Mottakelse i Oslo r?dhus
Byr?d for n?ring og eierskap, Rina Mariann Hansen ?nsker velkommen i bankettsalen.
Foto: Even Kleppa/Kleppa Media/University of Oslo
Enabling technologies in future health care
Sven Even Borgos, SINTEF:
Nanoformulated mRNA therapeutics are changing medicine. Vaccines - and beyond!
Foto: Even Kleppa/Kleppa Media/University of Oslo
The chair of Young Talents
Aksel Faanes Persson, SINTEF Digital.
Foto: Even Kleppa/Kleppa Media/University of Oslo
Speaker at Young Talents
Ali Areffard, Disease Area Head Immuno-Oncology, Bristol Myers Squibb
Foto: Even Kleppa/Kleppa Media/University of Oslo
Trends and Needs in Clinical Trials
Andreas Heddini, Vice President Medical and Regulatory Affairs, Nordics, AstraZeneca.
Foto: Even Kleppa/Kleppa Media/University of Oslo
Speaker at Young Talents
Borghild Hillestad, Director of Fish Welfare, Viking Aqua AS
Foto: Even Kleppa/Kleppa Media/University of Oslo
Speaker at Young Talents
Erik Paulshus, Research Scientist, Veterin?rinstituttet - Norwegian Veterinary Institute
Foto: Even Kleppa/Kleppa Media/University of Oslo
Speaker at Young Talents
Eva Marit Hystad Byhr?, Project Manager, Denofa/Pronofa Ecosystems
Foto: Even Kleppa/Kleppa Media/University of Oslo
Speaker at Young Talents
Fr?ydis Sved Skottvoll, Research Scientist, SINTEF Digital
Foto: Even Kleppa/Kleppa Media/University of Oslo
Speaker at Young Talents
Georg Vo Beiske, CEO, Tribune Therapeautics
Foto: Even Kleppa/Kleppa Media/University of Oslo
Speaker at Young Talents
Ingvild Gudim, Senior Adviser, Medical devices, Legemiddelverket - The Norwegian Medicines Agency
Foto: Even Kleppa/Kleppa Media/University of Oslo
Bridging the gap between academia and industry
Panel discussion with Hilde Nebb, Innovation director and Professor, UiO Growth House, Per Morten Sandset, Vice-Rector for Research and Innovation, UiO and Leader, Health&Care Advisory Board / R?det for HelseOmsorg21 and Bj?rn Atle Bj?rnbeth CEO, Oslo University Hospital
Foto: Even Kleppa/Kleppa Media/University of Oslo
Winner of Pitching Contest
From left: Andre Breg?rd from Novo Nordisk, Jan B?rge Jakobsen from Bayer, Georg Vo Beiske, Tribune Therapeutics, Morten Egeberg SPARK Norway and Director UiO:Life Science, Carl Henrik G?rbitz.
Foto: Even Kleppa/Kleppa Media/University of Oslo
Young Talents - Career Opportunities beyond Academia
Foto: Even Kleppa/Kleppa Media/University of Oslo
Parallel Session: Artificial Intelligence
Victor Greiff, UiO delivered the talk "AI-based mining of adaptive immunity for in silico diagnostics and therapeutics design".
Foto: Even Kleppa/Kleppa Media/University of Oslo
Evalueringen av konferansen viser at den betydelige innsatsen som har v?rt nedlagt i planlegging og gjennomf?ring har gitt frukter i form av meget forn?yde deltagere, uttaler direkt?r Carl Henrik G?rbitz i UiO:Livsvitenskap. Han takker samtidig partnerne Oslo Science City, Oslo universitetssykehus, SINTEF, LMI, The Life Science Cluster, Oslo Cancer Cluster og Oslo kommune og industripartnerne for konstruktivt 亚博娱乐官网_亚博pt手机客户端登录 som har resultert i en godt bes?kt og vellykket konferanse.
Universitetet i Oslo var hovedarrang?r av konferansen, som ble gjennomf?rt som et Oslo Science City Arena-arrangement med utvalgte industripartnere Bayer, Novo Nordisk, AstraZeneca, Boston Consulting Group og Microsoft med p? laget.